MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02020cam a2200313 4500 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9241207752 |
| 035 ## - |
|---|
| -- |
(Sirsi) 9241207752 |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WM 270 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
890210s1989 eng |
| 110 1# - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
WHO Expert Committee on Drug Dependence. |
| 242 10 - TRANSLATION OF TITLE BY CATALOGING AGENCY |
|---|
| Title |
Comité OMS d' experts de la pharmacodépendance [réuni à Genève, 18-23 avril 1988] : |
| Remainder of title |
vingt-cinquième rapport |
| 242 10 - TRANSLATION OF TITLE BY CATALOGING AGENCY |
|---|
| Title |
Comité de Expertos de la OMS en Farmacodependencia [se reunió en Ginebra del 18 al 23 de abril de 1988] : |
| Remainder of title |
25 informe |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
WHO Expert Committee on Drug Dependence [meeting held in Geneva from 18 to 23 April 1988] : |
| Remainder of title |
twenty-fifth report. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Geneva : |
| Name of publisher, distributor, etc. |
World Health Organization, |
| Date of publication, distribution, etc. |
1989. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
48 p. |
| 440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
World Health Organization technical report series ; |
| Volume/sequential designation |
no. 775 |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Conveys the views and recommendations of an expert committee commissioned to assess selected narcotic drugs and psychotropic substances and to determine which should be recommended for control under existing international treaties. Evaluations and recommendations are presented for 14 substances in the categories of sedative-hypnotics, opioid agonist-antagonist analgesics, and stimulants. Recommendations for scheduling or descheduling are based on ratings of therapeutic usefulness as well as the potential for abuse. For the opioid agonist-antagonist analgesics, the report provides a general explanation of criteria for scheduling, including a discussion of mechanisms of pharmacologic actions that influence drug-seeking behaviour and dependence and form the basis of the committees evaluations. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
chi eng fre rus spa. |
| 550 ## - ISSUING BODY NOTE |
|---|
| Issuing body note |
WHODOC |
| 561 ## - OWNERSHIP AND CUSTODIAL HISTORY |
|---|
| History |
WHO monograph |
| 596 ## - |
|---|
| -- |
4 |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Substance-related disorders. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Alcoholism and Drug Abuse. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
NLM Classification Scheme |
| Koha item type |
Books |
